Skip to main content
Premium Trial:

Request an Annual Quote

Gene Network Offers Biosimulation in Clinical Setting

NEW YORK, Nov. 30 (GenomeWeb News) - Gene Network Sciences will provide computer models to improve clinical trial success rates for cancer patients at the Mary Crowley Medical Research Center, the company said today.


Under the partnership agreement, Gene Network will be compensated per-patient.


The Dallas, TX-based medical facility will use biosimulation to test which therapies have the best clinical outcomes based on actual cancer patients' individual gene-expression data, the company said.


Gene Network processes biological data to develop computer simulations of cells, tissues, and organs for the purpose of improving cancer drug research and patient treatment, the firm said. By filtering out drug candidates in computer models fed with patient data, specialists may be able to better identify better drugs.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.